A Massive Blow To Covid Treatments? FDA Abruptly Decides To Limit Use Of 2 Monoclonal Antibodies Amidst Omicron Wave

A Massive Blow To Covid Treatments? FDA Abruptly Decides To Limit Use Of 2 Monoclonal Antibodies Amidst Omicron Wave

There has been a lot of fuss all over the Internet about the potential treatments against the covid 19 – the disease triggered by the novel coronavirus. While not everyone out there is excited about the covid vaccines due to fears involving potential side effects, a lot of people became more and more enthusiastic about potential and viable covid treatments.

WHO addresses viable covid treatments 

Not too long ago, we were revealing that on the official WHO website, the organization is recommending two new drugs for treating covid 19.

It’s important to have new treatments for the disease that made the world pause for the past two years.

On the official WHO website, the extent to which these medicines will save lives depends on how widely available and affordable they will be.

Check out the complete details about the two treatments in the previous article we shared not too long ago. 

The FDA drops news about monoclonal antibodies 

The US FDA just disapproved of some treatments because they are ineffective against Omicron. On the other hand, the organization addressed what options remain that ARE effective.

Check out this relevant tweet below.

Washington Post notes that The Food and Drug Administration on Monday took two monoclonal antibody therapies off the list of covid-19 treatments for now.

The organization revealed that the medications should not be used anywhere in the United States because they are ineffective against the dominant omicron variant.

“As a result, the Department of Health and Human Services, which distributes covid treatments to states, notified state health officials that it has halted distribution of the antibody medications made by Regeneron Pharmaceuticals and Eli Lilly, according to an email sent to the states and obtained by The Washington Post.”

FDA revises decision

The FDA revised their decision about the use of the treatments and noted the following:


On Twitter, the notes continued and revealed the following data:


Stay tuned for more news about the covid 19 vaccines and viable treatments. 


Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.